deltatrials
Unknown PHASE1/PHASE2 INTERVENTIONAL NCT02230163

Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins (CHIKIVIG-01)

Prevention of Chikungunya Infection in Neonates: Clinical Evaluation of Anti-CHIKV Hyperimmune Intravenous Immunoglobulins

Sponsor: Centre Hospitalier Universitaire de la Guadeloupe

Conditions Chikungunya Virus Infection
Interventions anti-CHIKV hyperimmune immunoglobulins
Updated 6 times since 2017 Last updated: Oct 31, 2014 Started: Sep 30, 2014 Primary completion: Oct 31, 2015 Completion: Apr 30, 2016
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02230163, this PHASE1/PHASE2 trial focuses on Chikungunya Virus Infection and remains ongoing. Sponsored by Centre Hospitalier Universitaire de la Guadeloupe, it has been updated 6 times since 2014, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotUnknown Status~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotUnknown Status~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotUnknown Status~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotUnknown~Sep 2024 – ~Mar 2025 · 6 months · monthly snapshotUnknown~Mar 2025 – present · 16 months · monthly snapshotUnknown

Change History

6 versions recorded

  1. Mar 2025 — Present [monthly]

    Unknown PHASE1/PHASE2

  2. Sep 2024 — Mar 2025 [monthly]

    Unknown PHASE1/PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Unknown PHASE1/PHASE2

    Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Unknown Status PHASE1_PHASE2

  5. Jun 2018 — Jan 2021 [monthly]

    Unknown Status PHASE1_PHASE2

▶ Show 1 earlier version

  1. Jan 2017 — Jun 2018 [monthly]

    Unknown Status PHASE1_PHASE2

    First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Centre Hospitalier Universitaire de la Guadeloupe
Data source: Centre Hospitalier Universitaire de la Guadeloupe

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations